COVID-19 Testing Devices
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Rapid Antigen Testing (RAT) for COVID-19 Market Research Report 2023
1 Rapid Antigen Testing (RAT) for COVID-19 Market Overview
1.1 Product Overview and Scope of Rapid Antigen Testing (RAT) for COVID-19
1.2 Rapid Antigen Testing (RAT) for COVID-19 Segment by Type
1.2.1 Global Rapid Antigen Testing (RAT) for COVID-19 Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Fluorescence Immunochromatography
1.2.3 Colloidal Gold Immunochromatography
1.2.4 Latex Immunochromatography
1.2.5 Others
1.3 Rapid Antigen Testing (RAT) for COVID-19 Segment by Application
1.3.1 Global Rapid Antigen Testing (RAT) for COVID-19 Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Community Testing
1.3.4 Other
1.4 Global Rapid Antigen Testing (RAT) for COVID-19 Market Size Estimates and Forecasts
1.4.1 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue 2017-2028
1.4.2 Global Rapid Antigen Testing (RAT) for COVID-19 Sales 2017-2028
1.4.3 Rapid Antigen Testing (RAT) for COVID-19 Market Size by Region: 2017 Versus 2021 Versus 2028
2 Rapid Antigen Testing (RAT) for COVID-19 Market Competition by Manufacturers
2.1 Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Manufacturers (2017-2022)
2.2 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Rapid Antigen Testing (RAT) for COVID-19 Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Sites, Area Served, Product Type
2.5 Rapid Antigen Testing (RAT) for COVID-19 Market Competitive Situation and Trends
2.5.1 Rapid Antigen Testing (RAT) for COVID-19 Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Rapid Antigen Testing (RAT) for COVID-19 Players Market Share by Revenue
2.5.3 Global Rapid Antigen Testing (RAT) for COVID-19 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Rapid Antigen Testing (RAT) for COVID-19 Retrospective Market Scenario by Region
3.1 Global Rapid Antigen Testing (RAT) for COVID-19 Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Rapid Antigen Testing (RAT) for COVID-19 Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Rapid Antigen Testing (RAT) for COVID-19 Market Facts & Figures by Country
3.3.1 North America Rapid Antigen Testing (RAT) for COVID-19 Sales by Country
3.3.2 North America Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Rapid Antigen Testing (RAT) for COVID-19 Market Facts & Figures by Country
3.4.1 Europe Rapid Antigen Testing (RAT) for COVID-19 Sales by Country
3.4.2 Europe Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Market Facts & Figures by Region
3.5.1 Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Sales by Region
3.5.2 Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Rapid Antigen Testing (RAT) for COVID-19 Market Facts & Figures by Country
3.6.1 Latin America Rapid Antigen Testing (RAT) for COVID-19 Sales by Country
3.6.2 Latin America Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Rapid Antigen Testing (RAT) for COVID-19 Market Facts & Figures by Country
3.7.1 Middle East and Africa Rapid Antigen Testing (RAT) for COVID-19 Sales by Country
3.7.2 Middle East and Africa Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Rapid Antigen Testing (RAT) for COVID-19 Historic Market Analysis by Type
4.1 Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Type (2017-2022)
4.2 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Type (2017-2022)
4.3 Global Rapid Antigen Testing (RAT) for COVID-19 Price by Type (2017-2022)
5 Global Rapid Antigen Testing (RAT) for COVID-19 Historic Market Analysis by Application
5.1 Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Application (2017-2022)
5.2 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Application (2017-2022)
5.3 Global Rapid Antigen Testing (RAT) for COVID-19 Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Abbott Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Quidel
6.2.1 Quidel Corporation Information
6.2.2 Quidel Description and Business Overview
6.2.3 Quidel Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Quidel Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.2.5 Quidel Recent Developments/Updates
6.3 ACCESS BIO
6.3.1 ACCESS BIO Corporation Information
6.3.2 ACCESS BIO Description and Business Overview
6.3.3 ACCESS BIO Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.3.4 ACCESS BIO Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.3.5 ACCESS BIO Recent Developments/Updates
6.4 CTK Biotech
6.4.1 CTK Biotech Corporation Information
6.4.2 CTK Biotech Description and Business Overview
6.4.3 CTK Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.4.4 CTK Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.4.5 CTK Biotech Recent Developments/Updates
6.5 SD Biosensor
6.5.1 SD Biosensor Corporation Information
6.5.2 SD Biosensor Description and Business Overview
6.5.3 SD Biosensor Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.5.4 SD Biosensor Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.5.5 SD Biosensor Recent Developments/Updates
6.6 Ellume
6.6.1 Ellume Corporation Information
6.6.2 Ellume Description and Business Overview
6.6.3 Ellume Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Ellume Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.6.5 Ellume Recent Developments/Updates
6.7 InBios
6.6.1 InBios Corporation Information
6.6.2 InBios Description and Business Overview
6.6.3 InBios Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.4.4 InBios Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.7.5 InBios Recent Developments/Updates
6.8 Celltrion
6.8.1 Celltrion Corporation Information
6.8.2 Celltrion Description and Business Overview
6.8.3 Celltrion Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Celltrion Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.8.5 Celltrion Recent Developments/Updates
6.9 AESKU.GROUP
6.9.1 AESKU.GROUP Corporation Information
6.9.2 AESKU.GROUP Description and Business Overview
6.9.3 AESKU.GROUP Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.9.4 AESKU.GROUP Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.9.5 AESKU.GROUP Recent Developments/Updates
6.10 ROCHE
6.10.1 ROCHE Corporation Information
6.10.2 ROCHE Description and Business Overview
6.10.3 ROCHE Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.10.4 ROCHE Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.10.5 ROCHE Recent Developments/Updates
6.11 BD
6.11.1 BD Corporation Information
6.11.2 BD Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.11.3 BD Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.11.4 BD Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.11.5 BD Recent Developments/Updates
6.12 OraSure Technologies
6.12.1 OraSure Technologies Corporation Information
6.12.2 OraSure Technologies Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.12.3 OraSure Technologies Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.12.4 OraSure Technologies Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.12.5 OraSure Technologies Recent Developments/Updates
6.13 Clip Health
6.13.1 Clip Health Corporation Information
6.13.2 Clip Health Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.13.3 Clip Health Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Clip Health Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.13.5 Clip Health Recent Developments/Updates
6.14 LumiraDx
6.14.1 LumiraDx Corporation Information
6.14.2 LumiraDx Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.14.3 LumiraDx Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.14.4 LumiraDx Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.14.5 LumiraDx Recent Developments/Updates
6.15 Princeton BioMeditech Corporation
6.15.1 Princeton BioMeditech Corporation Corporation Information
6.15.2 Princeton BioMeditech Corporation Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.15.3 Princeton BioMeditech Corporation Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Princeton BioMeditech Corporation Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.15.5 Princeton BioMeditech Corporation Recent Developments/Updates
6.16 RapiGEN Inc.
6.16.1 RapiGEN Inc. Corporation Information
6.16.2 RapiGEN Inc. Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.16.3 RapiGEN Inc. Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.16.4 RapiGEN Inc. Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.16.5 RapiGEN Inc. Recent Developments/Updates
6.17 Orient Gene
6.17.1 Orient Gene Corporation Information
6.17.2 Orient Gene Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.17.3 Orient Gene Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Orient Gene Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.17.5 Orient Gene Recent Developments/Updates
6.18 Wondfo Biotech
6.18.1 Wondfo Biotech Corporation Information
6.18.2 Wondfo Biotech Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.18.3 Wondfo Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Wondfo Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.18.5 Wondfo Biotech Recent Developments/Updates
6.19 Ihealth (Andon Health)
6.19.1 Ihealth (Andon Health) Corporation Information
6.19.2 Ihealth (Andon Health) Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.19.3 Ihealth (Andon Health) Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Ihealth (Andon Health) Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.19.5 Ihealth (Andon Health) Recent Developments/Updates
6.20 Wantai BioPharm
6.20.1 Wantai BioPharm Corporation Information
6.20.2 Wantai BioPharm Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.20.3 Wantai BioPharm Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Wantai BioPharm Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.20.5 Wantai BioPharm Recent Developments/Updates
6.21 Biotest Biotech
6.21.1 Biotest Biotech Corporation Information
6.21.2 Biotest Biotech Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.21.3 Biotest Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Biotest Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.21.5 Biotest Biotech Recent Developments/Updates
6.22 Shenzhen YHLO Biotech
6.22.1 Shenzhen YHLO Biotech Corporation Information
6.22.2 Shenzhen YHLO Biotech Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.22.3 Shenzhen YHLO Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.22.4 Shenzhen YHLO Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.22.5 Shenzhen YHLO Biotech Recent Developments/Updates
6.23 Vazyme Biotech
6.23.1 Vazyme Biotech Corporation Information
6.23.2 Vazyme Biotech Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.23.3 Vazyme Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.23.4 Vazyme Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.23.5 Vazyme Biotech Recent Developments/Updates
6.24 EasyDiagnosis Biomedicine
6.24.1 EasyDiagnosis Biomedicine Corporation Information
6.24.2 EasyDiagnosis Biomedicine Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.24.3 EasyDiagnosis Biomedicine Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.24.4 EasyDiagnosis Biomedicine Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.24.5 EasyDiagnosis Biomedicine Recent Developments/Updates
6.25 Beijing Hotgen Biotech
6.25.1 Beijing Hotgen Biotech Corporation Information
6.25.2 Beijing Hotgen Biotech Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.25.3 Beijing Hotgen Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.25.4 Beijing Hotgen Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.25.5 Beijing Hotgen Biotech Recent Developments/Updates
6.26 Assure Tech
6.26.1 Assure Tech Corporation Information
6.26.2 Assure Tech Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.26.3 Assure Tech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.26.4 Assure Tech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.26.5 Assure Tech Recent Developments/Updates
6.27 Hangzhou AllTest Biotech
6.27.1 Hangzhou AllTest Biotech Corporation Information
6.27.2 Hangzhou AllTest Biotech Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.27.3 Hangzhou AllTest Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.27.4 Hangzhou AllTest Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.27.5 Hangzhou AllTest Biotech Recent Developments/Updates
6.28 ACON Biotech
6.28.1 ACON Biotech Corporation Information
6.28.2 ACON Biotech Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.28.3 ACON Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.28.4 ACON Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.28.5 ACON Biotech Recent Developments/Updates
6.29 BGI Genomics
6.29.1 BGI Genomics Corporation Information
6.29.2 BGI Genomics Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.29.3 BGI Genomics Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.29.4 BGI Genomics Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.29.5 BGI Genomics Recent Developments/Updates
6.30 Lepu Medical Technology
6.30.1 Lepu Medical Technology Corporation Information
6.30.2 Lepu Medical Technology Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.30.3 Lepu Medical Technology Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
6.30.4 Lepu Medical Technology Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.30.5 Lepu Medical Technology Recent Developments/Updates
7 Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Cost Analysis
7.1 Rapid Antigen Testing (RAT) for COVID-19 Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Rapid Antigen Testing (RAT) for COVID-19
7.4 Rapid Antigen Testing (RAT) for COVID-19 Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Rapid Antigen Testing (RAT) for COVID-19 Distributors List
8.3 Rapid Antigen Testing (RAT) for COVID-19 Customers
9 Rapid Antigen Testing (RAT) for COVID-19 Market Dynamics
9.1 Rapid Antigen Testing (RAT) for COVID-19 Industry Trends
9.2 Rapid Antigen Testing (RAT) for COVID-19 Market Drivers
9.3 Rapid Antigen Testing (RAT) for COVID-19 Market Challenges
9.4 Rapid Antigen Testing (RAT) for COVID-19 Market Restraints
10 Global Market Forecast
10.1 Rapid Antigen Testing (RAT) for COVID-19 Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Rapid Antigen Testing (RAT) for COVID-19 by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Rapid Antigen Testing (RAT) for COVID-19 by Type (2023-2028)
10.2 Rapid Antigen Testing (RAT) for COVID-19 Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Rapid Antigen Testing (RAT) for COVID-19 by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Rapid Antigen Testing (RAT) for COVID-19 by Application (2023-2028)
10.3 Rapid Antigen Testing (RAT) for COVID-19 Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Rapid Antigen Testing (RAT) for COVID-19 by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Rapid Antigen Testing (RAT) for COVID-19 by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Rapid Antigen Testing (RAT) for COVID-19 Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Rapid Antigen Testing (RAT) for COVID-19 Market Competitive Situation by Manufacturers in 2021
Table 5. Global Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Rapid Antigen Testing (RAT) for COVID-19 Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Sites and Area Served
Table 11. Manufacturers Rapid Antigen Testing (RAT) for COVID-19 Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Rapid Antigen Testing (RAT) for COVID-19 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rapid Antigen Testing (RAT) for COVID-19 as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Region (2017-2022) & (K Units)
Table 16. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Region (2017-2022)
Table 17. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Region (2017-2022)
Table 19. North America Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2017-2022) & (K Units)
Table 20. North America Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Country (2017-2022)
Table 21. North America Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Country (2017-2022)
Table 23. Europe Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2017-2022) & (K Units)
Table 24. Europe Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Country (2017-2022)
Table 25. Europe Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Region (2017-2022)
Table 31. Latin America Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Country (2017-2022)
Table 33. Latin America Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Country (2017-2022)
Table 39. Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Type (2017-2022) & (K Units)
Table 40. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Type (2017-2022)
Table 41. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Share by Type (2017-2022)
Table 43. Global Rapid Antigen Testing (RAT) for COVID-19 Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units) by Application (2017-2022)
Table 45. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Application (2017-2022)
Table 46. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Share by Application (2017-2022)
Table 48. Global Rapid Antigen Testing (RAT) for COVID-19 Price by Application (2017-2022) & (US$/Unit)
Table 49. Abbott Corporation Information
Table 50. Abbott Description and Business Overview
Table 51. Abbott Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Abbott Rapid Antigen Testing (RAT) for COVID-19 Product
Table 53. Abbott Recent Developments/Updates
Table 54. Quidel Corporation Information
Table 55. Quidel Description and Business Overview
Table 56. Quidel Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Quidel Rapid Antigen Testing (RAT) for COVID-19 Product
Table 58. Quidel Recent Developments/Updates
Table 59. ACCESS BIO Corporation Information
Table 60. ACCESS BIO Description and Business Overview
Table 61. ACCESS BIO Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. ACCESS BIO Rapid Antigen Testing (RAT) for COVID-19 Product
Table 63. ACCESS BIO Recent Developments/Updates
Table 64. CTK Biotech Corporation Information
Table 65. CTK Biotech Description and Business Overview
Table 66. CTK Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. CTK Biotech Rapid Antigen Testing (RAT) for COVID-19 Product
Table 68. CTK Biotech Recent Developments/Updates
Table 69. SD Biosensor Corporation Information
Table 70. SD Biosensor Description and Business Overview
Table 71. SD Biosensor Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. SD Biosensor Rapid Antigen Testing (RAT) for COVID-19 Product
Table 73. SD Biosensor Recent Developments/Updates
Table 74. Ellume Corporation Information
Table 75. Ellume Description and Business Overview
Table 76. Ellume Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Ellume Rapid Antigen Testing (RAT) for COVID-19 Product
Table 78. Ellume Recent Developments/Updates
Table 79. InBios Corporation Information
Table 80. InBios Description and Business Overview
Table 81. InBios Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. InBios Rapid Antigen Testing (RAT) for COVID-19 Product
Table 83. InBios Recent Developments/Updates
Table 84. Celltrion Corporation Information
Table 85. Celltrion Description and Business Overview
Table 86. Celltrion Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Celltrion Rapid Antigen Testing (RAT) for COVID-19 Product
Table 88. Celltrion Recent Developments/Updates
Table 89. AESKU.GROUP Corporation Information
Table 90. AESKU.GROUP Description and Business Overview
Table 91. AESKU.GROUP Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. AESKU.GROUP Rapid Antigen Testing (RAT) for COVID-19 Product
Table 93. AESKU.GROUP Recent Developments/Updates
Table 94. ROCHE Corporation Information
Table 95. ROCHE Description and Business Overview
Table 96. ROCHE Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. ROCHE Rapid Antigen Testing (RAT) for COVID-19 Product
Table 98. ROCHE Recent Developments/Updates
Table 99. BD Corporation Information
Table 100. BD Description and Business Overview
Table 101. BD Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. BD Rapid Antigen Testing (RAT) for COVID-19 Product
Table 103. BD Recent Developments/Updates
Table 104. OraSure Technologies Corporation Information
Table 105. OraSure Technologies Description and Business Overview
Table 106. OraSure Technologies Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. OraSure Technologies Rapid Antigen Testing (RAT) for COVID-19 Product
Table 108. OraSure Technologies Recent Developments/Updates
Table 109. Clip Health Corporation Information
Table 110. Clip Health Description and Business Overview
Table 111. Clip Health Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Clip Health Rapid Antigen Testing (RAT) for COVID-19 Product
Table 113. Clip Health Recent Developments/Updates
Table 114. LumiraDx Corporation Information
Table 115. LumiraDx Description and Business Overview
Table 116. LumiraDx Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. LumiraDx Rapid Antigen Testing (RAT) for COVID-19 Product
Table 118. LumiraDx Recent Developments/Updates
Table 119. Princeton BioMeditech Corporation Corporation Information
Table 120. Princeton BioMeditech Corporation Description and Business Overview
Table 121. Princeton BioMeditech Corporation Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Princeton BioMeditech Corporation Rapid Antigen Testing (RAT) for COVID-19 Product
Table 123. Princeton BioMeditech Corporation Recent Developments/Updates
Table 124. RapiGEN Inc. Corporation Information
Table 125. RapiGEN Inc. Description and Business Overview
Table 126. RapiGEN Inc. Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. RapiGEN Inc. Rapid Antigen Testing (RAT) for COVID-19 Product
Table 128. RapiGEN Inc. Recent Developments/Updates
Table 129. Orient Gene Corporation Information
Table 130. Orient Gene Description and Business Overview
Table 131. Orient Gene Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Orient Gene Rapid Antigen Testing (RAT) for COVID-19 Product
Table 133. Orient Gene Recent Developments/Updates
Table 134. Wondfo Biotech Corporation Information
Table 135. Wondfo Biotech Description and Business Overview
Table 136. Wondfo Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. Wondfo Biotech Rapid Antigen Testing (RAT) for COVID-19 Product
Table 138. Wondfo Biotech Recent Developments/Updates
Table 139. Ihealth (Andon Health) Corporation Information
Table 140. Ihealth (Andon Health) Description and Business Overview
Table 141. Ihealth (Andon Health) Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 142. Ihealth (Andon Health) Rapid Antigen Testing (RAT) for COVID-19 Product
Table 143. Ihealth (Andon Health) Recent Developments/Updates
Table 144. Wantai BioPharm Corporation Information
Table 145. Wantai BioPharm Description and Business Overview
Table 146. Wantai BioPharm Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 147. Wantai BioPharm Rapid Antigen Testing (RAT) for COVID-19 Product
Table 148. Wantai BioPharm Recent Developments/Updates
Table 149. Biotest Biotech Corporation Information
Table 150. Biotest Biotech Description and Business Overview
Table 151. Biotest Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 152. Biotest Biotech Rapid Antigen Testing (RAT) for COVID-19 Product
Table 153. Biotest Biotech Recent Developments/Updates
Table 154. Shenzhen YHLO Biotech Corporation Information
Table 155. Shenzhen YHLO Biotech Description and Business Overview
Table 156. Shenzhen YHLO Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 157. Shenzhen YHLO Biotech Rapid Antigen Testing (RAT) for COVID-19 Product
Table 158. Shenzhen YHLO Biotech Recent Developments/Updates
Table 159. Vazyme Biotech Corporation Information
Table 160. Vazyme Biotech Description and Business Overview
Table 161. Vazyme Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 162. Vazyme Biotech Rapid Antigen Testing (RAT) for COVID-19 Product
Table 163. Vazyme Biotech Recent Developments/Updates
Table 164. EasyDiagnosis Biomedicine Corporation Information
Table 165. EasyDiagnosis Biomedicine Description and Business Overview
Table 166. EasyDiagnosis Biomedicine Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 167. EasyDiagnosis Biomedicine Rapid Antigen Testing (RAT) for COVID-19 Product
Table 168. EasyDiagnosis Biomedicine Recent Developments/Updates
Table 169. Beijing Hotgen Biotech Corporation Information
Table 170. Beijing Hotgen Biotech Description and Business Overview
Table 171. Beijing Hotgen Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 172. Beijing Hotgen Biotech Rapid Antigen Testing (RAT) for COVID-19 Product
Table 173. Beijing Hotgen Biotech Recent Developments/Updates
Table 174. Assure Tech Corporation Information
Table 175. Assure Tech Description and Business Overview
Table 176. Assure Tech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 177. Assure Tech Rapid Antigen Testing (RAT) for COVID-19 Product
Table 178. Assure Tech Recent Developments/Updates
Table 179. Hangzhou AllTest Biotech Corporation Information
Table 180. Hangzhou AllTest Biotech Description and Business Overview
Table 181. Hangzhou AllTest Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 182. Hangzhou AllTest Biotech Rapid Antigen Testing (RAT) for COVID-19 Product
Table 183. Hangzhou AllTest Biotech Recent Developments/Updates
Table 184. ACON Biotech Corporation Information
Table 185. ACON Biotech Description and Business Overview
Table 186. ACON Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 187. ACON Biotech Rapid Antigen Testing (RAT) for COVID-19 Product
Table 188. ACON Biotech Recent Developments/Updates
Table 189. BGI Genomics Corporation Information
Table 190. BGI Genomics Description and Business Overview
Table 191. BGI Genomics Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 192. BGI Genomics Rapid Antigen Testing (RAT) for COVID-19 Product
Table 193. BGI Genomics Recent Developments/Updates
Table 194. Lepu Medical Technology Corporation Information
Table 195. Lepu Medical Technology Description and Business Overview
Table 196. Lepu Medical Technology Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 197. Lepu Medical Technology Rapid Antigen Testing (RAT) for COVID-19 Product
Table 198. Lepu Medical Technology Recent Developments/Updates
Table 199. Production Base and Market Concentration Rate of Raw Material
Table 200. Key Suppliers of Raw Materials
Table 201. Rapid Antigen Testing (RAT) for COVID-19 Distributors List
Table 202. Rapid Antigen Testing (RAT) for COVID-19 Customers List
Table 203. Rapid Antigen Testing (RAT) for COVID-19 Market Trends
Table 204. Rapid Antigen Testing (RAT) for COVID-19 Market Drivers
Table 205. Rapid Antigen Testing (RAT) for COVID-19 Market Challenges
Table 206. Rapid Antigen Testing (RAT) for COVID-19 Market Restraints
Table 207. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Forecast by Type (2023-2028) & (K Units)
Table 208. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share Forecast by Type (2023-2028)
Table 209. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 210. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share Forecast by Type (2023-2028)
Table 211. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Forecast by Application (2023-2028) & (K Units)
Table 212. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share Forecast by Application (2023-2028)
Table 213. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 214. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share Forecast by Application (2023-2028)
Table 215. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Forecast by Region (2023-2028) & (K Units)
Table 216. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share Forecast by Region (2023-2028)
Table 217. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 218. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share Forecast by Region (2023-2028)
Table 219. Research Programs/Design for This Report
Table 220. Key Data Information from Secondary Sources
Table 221. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Rapid Antigen Testing (RAT) for COVID-19
Figure 2. Global Rapid Antigen Testing (RAT) for COVID-19 Market Share by Type in 2021 & 2028
Figure 3. Fluorescence Immunochromatography Product Picture
Figure 4. Colloidal Gold Immunochromatography Product Picture
Figure 5. Latex Immunochromatography Product Picture
Figure 6. Others Product Picture
Figure 7. Global Rapid Antigen Testing (RAT) for COVID-19 Market Share by Application in 2021 & 2028
Figure 8. Hospitals
Figure 9. Community Testing
Figure 10. Other
Figure 11. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Rapid Antigen Testing (RAT) for COVID-19 Market Size (2017-2028) & (US$ Million)
Figure 13. Global Rapid Antigen Testing (RAT) for COVID-19 Sales (2017-2028) & (K Units)
Figure 14. Rapid Antigen Testing (RAT) for COVID-19 Sales Share by Manufacturers in 2021
Figure 15. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Rapid Antigen Testing (RAT) for COVID-19 Players: Market Share by Revenue in 2021
Figure 17. Rapid Antigen Testing (RAT) for COVID-19 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Region (2017-2022)
Figure 19. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Region in 2021
Figure 20. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Region (2017-2022)
Figure 21. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Region in 2021
Figure 22. United States Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. China Taiwan Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Colombia Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. UAE Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of Rapid Antigen Testing (RAT) for COVID-19 by Type (2017-2022)
Figure 46. Manufacturing Cost Structure of Rapid Antigen Testing (RAT) for COVID-19
Figure 47. Manufacturing Process Analysis of Rapid Antigen Testing (RAT) for COVID-19
Figure 48. Rapid Antigen Testing (RAT) for COVID-19 Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Quidel ACCESS BIO CTK Biotech SD Biosensor Ellume InBios Celltrion AESKU.GROUP ROCHE BD OraSure Technologies Clip Health LumiraDx Princeton BioMeditech Corporation RapiGEN Inc. Orient Gene Wondfo Biotech Ihealth (Andon Health) Wantai BioPharm Biotest Biotech Shenzhen YHLO Biotech Vazyme Biotech EasyDiagnosis Biomedicine Beijing Hotgen Biotech Assure Tech Hangzhou AllTest Biotech ACON Biotech BGI Genomics Lepu Medical Technology